6/26/2025

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive top-line results from VEGA-3, the second pivotal Phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) in treating presbyopia. Presbyopia is the progressive loss of the ability to focus on close objects that results in blurred near vision and eye strain, particularly in dim lighting conditions.

Source: Yahoo

6/26/2025

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that Viatris Inc. ("Viatris"), has secured regulatory approval from China's National Medical Products Administration (NMPA) for YUPELRI® (revefenacin) inhalation solution, the first once–daily nebulized long–acting muscarinic antagonist (LAMA) approved for maintenance treatment of chronic obstructive pulmonary disease (COPD) in China.

Source: Yahoo

6/26/2025

Viatris Inc. announced positive top-line results from VEGA-3, the second pivotal Phase 3 trial evaluating MR-141 in treating presbyopia. Presbyopia is the progressive loss of the ability to focus on...

Source: Finnhub

6/25/2025

Viatris faces downside risk from regulatory challenges, macro headwinds, and muted growth. Click to learn more on why VTRS may be a value trap.

Source: SeekingAlpha

6/24/2025

Viatris has significantly underperformed the S&P 500 over the past year, and analysts remain cautious about the stock’s prospects.

Source: Yahoo

6/22/2025

Greenlight Capital outperforms with an 8.2% Q1 2025 return. Check out the major stake increases and selective trims in the portfolio.

Source: SeekingAlpha

6/20/2025

EMA's CHMP: * POSITIVE OPINION WAS ADOPTED FOR OGSIVEO, FOR THETREATMENT OFADULTS WITH PROGRESSING DESMOID TUMOURS * NINTEDANIB VIATRIS GOT POSITIVE OPINION FOR...

Source: Finnhub

6/18/2025

This is our monthly dashboard series on Healthcare and Pharma stocks. Read the full analysis here, and which 10 healthcare stocks were cheaper than their peers in June 2025.

Source: SeekingAlpha

6/18/2025

Smarter Web Company PLC: * ANDREW SMITH REPORTS 2.90% STAKE IN SMARTER WEB COMPANYPLC ASAT JUNE 13 VERSUS PRIOR STAKE OF 10.39% - FILINGSource text:Further company coverage: ...

Source: Finnhub

6/17/2025

Viatris Inc. stock falls Tuesday, underperforms market

Source: MarketWatch

6/17/2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Source: Yahoo

6/17/2025

Viatris’s stock price has taken a beating over the past six months, shedding 27.7% of its value and falling to $9.10 per share. This might have investors contemplating their next move.

Source: Yahoo

6/13/2025

Viatris Inc. stock falls Friday, underperforms market

Source: MarketWatch

6/13/2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 8.4%. This drawdown was discouraging since the S&P 500 held its ground.

Source: Yahoo

6/12/2025

Viatris Inc. (Nasdaq: VTRS) will report second quarter 2025 financial results on Thursday, August 7, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.

Source: Yahoo

6/12/2025

Viatris Inc. stock rises Thursday, outperforms market

Source: MarketWatch

6/12/2025

Analyst projections suggest the top 10 S&P 500 dividend dogs could deliver net gains of 27% to 53% by June 2026. Learn more about the dividend dogs here.

Source: SeekingAlpha

6/10/2025

SDZNY, TEVA, and VTRS show resilience with strong biosimilar pipelines and margin strategies amid industry headwinds.

Source: Yahoo

6/9/2025

Sandoz, Teva and Viatris are navigating generic drug pricing pressure with scale, complex generics and cost cuts.

Source: Yahoo

6/9/2025

Viatris Inc. (NASDAQ:VTRS) Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 10:40 AM ETCompany ParticipantsCorinne M.

Source: SeekingAlpha